GlobeNewswire by notified

Yara International and Oerth Bio collaborate to tackle crop resilience

Share

Durham, North Carolina, November 15, 2022 — Oerth Bio (pronounced “earth”), an agricultural biotechnology company pioneering targeted protein degraders in plants, and Yara International, a world leading crop nutrition company, today announced a first-of-its-kind collaboration applying Oerth’s novel protein degrader technology to crop efficiency applications.

The collaboration will focus on boosting plant resilience to combat escalating climate stress impacting crop production and farm economics. The companies will co-develop novel products to improve nutrient use efficiency and strengthen plant resilience to climate change. By linking Yara’s agronomic expertise in crop physiology and crop nutrition to Oerth’s specialization in rational design of plant protein degraders, the collaboration will develop unique products to activate precision plant stress tolerance.

“This collaboration will be a game-changing win for farmers — a completely new product range to safeguard crop quality and yield, even as climate challenges increase and become more unpredictable.”

Lars Roesag, EVP Corporate Development & Deputy CEO, Yara International

Yara sees tremendous promise in the new technology, as indicated by Yara Senior Vice President of Agronomy and R&D, Markus Himken, “This collaboration will catapult Yara’s competitive footprint, offering farmers plant nutrition solutions specifically targeting plant resilience and improved crop quality — setting a new sustainable agriculture paradigm.”

The collaboration merges Yara’s mission for a nature-positive food future, and Oerth’s vision that protein degrader technology will transform agriculture. Oerth’s Attune™ platform harnesses a naturally occurring protein recycling system that precisely tunes climate-adaptable crops.

The companies are devoted to the idea that human health begins with plant health. They share a foundational commitment to sustainable and nutritious food system solutions, as Apostolos Klontzaris, Senior Vice President of Corporate and Business Development at Oerth Bio remarked, “This will be the first in a series of solutions that will enable crops to withstand climate change, enhance input efficiency, and improve food nutrient profiles. We are inspiring and motivating the necessary transition to high-quality food. Such mission-critical collaborations symbolize our longstanding commitment to humanity.

“We believe PROTAC® degrader technology is the sustainable answer to a safe, productive, resilient, and more nutritious food system. By partnering with agricultural leaders like Yara, we are poised to deliver tangible benefit to farmers, as they face fast emerging operational complexity and climate challenges."

John Dombrosky, CEO, Oerth Bio

About Yara

Yara grows knowledge to responsibly feed the world and protect the planet. Supporting our vision of a world without hunger and a planet respected, we pursue a strategy of sustainable value growth, promoting climate-friendly crop nutrition and zero-emission energy solutions. Yara’s ambition is focused on growing a nature positive food future that creates value for our customers, shareholders and society at large and delivers a more sustainable food value chain.

To achieve our ambition, we have taken the lead in developing digital farming tools for precision farming and work closely with partners throughout the food value chain to improve the efficiency and sustainability of food production. Through our focus on clean ammonia production, we aim to enable the hydrogen economy, driving a green transition of shipping, fertilizer production and other energy intensive industries.

Founded in 1905 to solve the emerging famine in Europe, Yara has established a unique position as the industry’s only global crop nutrition company. We operate an integrated business model with around 17,000 employees and operations in over 60 countries, with a proven track record of strong returns. In 2021, Yara reported revenues of USD 16.6 billion.

For more information about the company, please visit www.yara.com

About Oerth Bio

Oerth Bio’s protein degrader technology for agriculture, aims to combine powerful farm efficacy with next-generation environmental sustainability. The technology is designed to deliver unparalleled safety of food and farm, while achieving superior field performance for farmers.

The core technological innovations driving Oerth Bio’s progress are:

• PROTAC® Molecules

PROteolysis TArgeting Chimeras (PROTAC) compounds are biologically enabled molecules designed to induce the modulation of specific proteins via the ubiquitin proteasome system. Each region of the PROTAC molecule plays a role in its specificity and potency.

• Attune™ Platform 

Attune™ is Oerth Bio’s proprietary R&D platform for developing PROTAC molecules for agriculture. Through a rational target-based design process, the platform creates and optimizes molecules for specific crop applications and outcomes.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

www.oerthbio.com

Media contact

Sr. Director, Communications
Oerth Bio
E-mail: laura.schuchart@oerthbio.com


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions3.5.2024 22:39:16 CEST | Press release

CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF APPLE INC. (“APPLE” OR THE “COMPANY”) COMMON STOCK AS OF THE CLOSE OF TRADING ON APRIL 29, 2024. THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A CURRENT APPLE SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. THIS ACTION IS NOT A “CLASS ACTION.” THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR MONETARY PAYMENT. IF YOU DO NOT OBJECT TO THE TERMS OF THE PROPOSED SETTLEMENT OR THE AMOUNT OF ATTORNEYS’ FEES AND EXPENSES DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY ACTION. The purpose of this Notice is to inform you of: (i) the pendency of the shareholder derivative action brought on beh

CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report3.5.2024 22:30:00 CEST | Press release

Basildon, May 3, 2024 CNH Industrial N.V. (NYSE: CNHI) today held its annual general meeting of shareholders. Shareholders re-appointed the Company’s director nominees, including Suzanne Heywood and Scott W. Wine as executive directors1, and Elizabeth Bastoni, Howard W. Buffett, Richard J. Kramer, Karen Linehan, Alessandro Nasi, Vagn Sørensen and Åsa Tamsons as non-executive directors. Shareholders also approved a dividend of $0.47 per common share (equivalent to a total distribution of approximately $585 million), and the AGM approved the Company’s Remuneration Policy. In other voting, shareholders appointed Deloitte Accountants B.V. as the independent auditor for the 2025 financial year and approved the Company’s 2023 financial statements prepared under IFRS. Details of all matters approved today by the AGM are available on the Company's website (www.cnh.com). *** The dividend is payable on May 29, 2024 to shareholders of record on May 13, 2024. Shareholders holding CNH common shares

Nokia Corporation: Repurchase of own shares on 03.05.20243.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons3.5.2024 19:48:16 CEST | Press release

Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. Details of the person discharging managerial responsibilities/person closely associated a)Name of the Board member/Executive/Associated PersonMaziar Mike Doustdar2 Reason for the notificationa)Position/statusExecutive Vice Presidentb)Initial notification/AmendmentInitial notification3 Details of the issuera)NameNovo Nordisk A/Sb)LEI549300DAQ1CVT6CXN342

Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release

Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r

HiddenA line styled icon from Orion Icon Library.Eye